Table 1 Association of RNF8 expression and clinical pathological features
From: RNF8 promotes epithelial-mesenchymal transition of breast cancer cells
Variables | N | RNF8-cytoplasmic N (%) | P | RNF8-Nuclear N (%) | P | ||||
|---|---|---|---|---|---|---|---|---|---|
Negative | Low score | High score | Negative | Low score | High score | ||||
- | + | ++ | - | + | ++ | ||||
Grade | Â | Â | Â | Â | 0.658 | Â | Â | Â | 0.659 |
 1, 2 | 31 | 6 (19.4) | 19 (61.3) | 6 (19.4) |  | 18 (58.1) | 10 (32.3) | 3 (9.7) |  |
 3 | 49 | 9 (18.4) | 34 (69.4) | 6 (12.2) |  | 29 (59.2) | 20 (40.8) | 0 (0) |  |
Stage | Â | Â | Â | Â | 0.299 | Â | Â | Â | 0.527 |
 II (A + B) | 62 | 13 (21.0) | 40 (64.5) | 9 (14.5) |  | 35 (56.5) | 26 (41.9) | 1 (1.6) |  |
 III (A + B + C) | 33 | 3 (9.1) | 25 (75.8) | 5 (15.2) |  | 22 (66.7) | 8 (24.2) | 3 (9.1) |  |
TNM-T | Â | Â | Â | Â | 0.848 | Â | Â | Â | 0.511 |
 T1 + T2 | 83 | 16 (19.3) | 54 (65.1) | 13 (15.7) |  | 50 (60.2) | 30 (36.1) | 3 (3.6) |  |
 T3 + T4 | 14 | 2 (14.3) | 11 (78.6) | 1 (7.1) |  | 10 (71.4) | 3 (21.4) | 1 (7.1) |  |
TNM-N | Â | Â | Â | Â | 0.874 | Â | Â | Â | 0.953 |
 N0 + N1 | 69 | 13 (18.8) | 47 (68.1) | 9 (13.0) |  | 44 (63.8) | 24 (34.8) | 1 (1.4) |  |
 N2 + N3 | 27 | 5 (18.5) | 18 (66.7) | 4 (14.8) |  | 18(66.7) | 6 (22.2) | 3 (11.1) |  |